SATB1 and laryngeal squamous cell carcinoma: Recent studies have shown aberrant expression of SATB1 in a variety of epithelial cancers, including melanoma, laryngeal squamous cell carcinoma, and carcinomas of the breast, colon, lung, ovary, and liver [18]–[24].